[Hub]/) : Traits : Cholesterol lowering medication :

chr19:9,982,334-12,196,190

Best TWAS P=1.56e-15 · Best GWAS P=1.39e-42 conditioned to 5.02e-07

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex CDKN2D 0.04 0.01 blup 360 0.01 3.1e-02 -3.1 5.8 8.1e-09 -0.26 0.46 0.03 TRUE
2 GTEx Adipose Subcutaneous EPOR 0.11 0.04 lasso 7 0.04 3.8e-04 -8.3 -7.9 2.1e-15 0.48 0.52 0.38 FALSE
3 GTEx Artery Aorta RGL3 0.15 0.00 enet 23 0.00 2.8e-01 2.3 5.7 1.1e-08 -0.18 0.06 0.04 TRUE
4 GTEx Cells Transformed fibroblasts CARM1 0.11 0.01 lasso 4 0.00 6.9e-01 -5.1 -5.2 1.8e-07 0.35 0.29 0.04 FALSE
5 GTEx Esophagus Mucosa SMARCA4 0.18 0.03 enet 15 0.09 8.2e-07 -4.8 6.6 4.2e-11 -0.36 0.95 0.00 FALSE
6 GTEx Esophagus Muscularis SMARCA4 0.16 0.00 lasso 6 0.03 7.2e-03 -8.3 6.8 1.2e-11 -0.39 0.17 0.08 TRUE
7 GTEx Skin Sun Exposed Lower leg YIPF2 0.05 0.05 lasso 2 0.04 1.6e-04 -5.1 5.2 2.4e-07 -0.33 0.53 0.29 FALSE
8 NTR Blood SMARCA4 0.07 0.06 lasso 11 0.06 9.0e-18 -6.9 6.9 6.8e-12 -0.38 1.00 0.00 TRUE
9 ROSMAP Brain Pre-frontal Cortex C19orf80 0.08 0.04 enet 17 0.05 3.1e-07 2.0 6.5 7.3e-11 -0.41 0.65 0.33 TRUE
10 YFS Blood SMARCA4 0.02 0.01 enet 3 0.00 9.2e-03 -4.7 6.6 4.3e-11 -0.39 0.15 0.07 TRUE
11 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma C19orf52 0.04 0.04 blup 27 0.03 1.7e-04 -5.8 6.0 1.9e-09 -0.37 0.00 1.00 FALSE
12 The Cancer Genome Atlas Brain Lower Grade Glioma KANK2 0.28 0.26 lasso 3 0.26 4.6e-29 5.6 5.6 2.3e-08 -0.02 0.88 0.12 TRUE
13 The Cancer Genome Atlas Prostate Adenocarcinoma KANK2 0.09 0.04 blup 76 0.06 9.5e-07 5.6 5.2 2.1e-07 -0.13 0.05 0.90 TRUE
14 The Cancer Genome Atlas Prostate Adenocarcinoma SPC24 0.06 0.00 enet 15 0.01 1.4e-02 -10.6 8.0 1.6e-15 -0.35 0.00 0.55 TRUE
15 The Cancer Genome Atlas Thyroid Carcinoma C19orf52 0.05 0.06 lasso 4 0.06 2.5e-06 -5.2 5.8 8.9e-09 -0.36 0.01 0.99 FALSE